WHO's advisory group to meet on 26 October to consider emergency use for Covaxin

·1-min read

Geneva: Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO's technical advisory group will meet on October 26 to consider emergency use listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin.

Taking to Twitter, Swaminathan said the WHO has been working closely with Bharat Biotech to complete the dossier.

"The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere," Dr Swaminathan tweeted.

Covaxin has been submitting data to WHO on a rolling basis and submitted additional information at WHO's request on 27 September.

"Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis & submitted additional info at WHO's request on 27 September. WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week," WHO had tweeted earlier this month.

Covaxin, India's first vaccine candidate for Covid-19 was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV)

Also See: WHO decision on Bharat Biotech's Covaxin emergency use listing likely next week

WHO's advisory group to meet on 26 Oct to decide on EUL for Covaxin says chief scientist Soumya Swaminathan

China's foreign ministry warns against 'possible manipulation' of WHO COVID-19 probe

Read more on India by Firstpost.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting